Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.6 |